Screener
Castle Biosciences CSTL Net debt / EBITDA
Net debt / EBITDA at other companies
Other financials
Where this comes from
Calculated from Castle Biosciences’s reported figures.
Based on the most recent quarter.
The source filing: Castle Biosciences’s 10-Q, filed November 3, 2025. Open the filing →
- Filed
- Nov 3, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001628280-25-048254
FAQ
- What is Castle Biosciences's net debt / EBITDA?
- Castle Biosciences (CSTL) reported net debt / EBITDA of -6.2× in Q3 2025.
- How has Castle Biosciences's net debt / EBITDA changed year-over-year?
- Castle Biosciences's net debt / EBITDA decreased by 12.5% year-over-year, from -5.5× to -6.2×.
- What does net debt / EBITDA mean?
- Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.
Ask your AI about Castle Biosciences's net debt / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude